Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chandler

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Molecular Genetics and Metabolism|February 10, 2006
Founder mutation causing infantile GM1-gangliosidosis in the Gypsy populationIvanka Sinigerska, David Chandler, Vijesh Vaghjiani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2019
Trends in the use of primary prophylactic colony-stimulating factors and neutropenia-related hospitalization in elderly cancer patients receiving myelosuppressive chemotherapy in the USA: 1995-2015Shuling Li, Jiannong Liu, Haifeng Guo, et al.
Physical Review Letters|August 29, 2014
Charge fluctuations in nanoscale capacitorsDavid T Limmer, Céline Merlet, Mathieu Salanne, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 9, 2017
Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional surveyA Brett Hauber, Brennan Mange, Mark A Price, et al.
Clinical and Experimental Dermatology|August 22, 2024
Tinea capitis in older people: clinical experience of 36 cases over 10 yearsAlexandro Bonifaz, María Alejandra Chacón-Ruiz, Javier Araiza, et al.
BMC Cancer|January 19, 2023
Patient perspectives on considerations, tradeoffs, and experiences with multiple myeloma treatment selection: a qualitative descriptive studyCarrie Dombeck, Teresa Swezey, Juan Marcos Gonzalez Sepulveda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2016
"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationaleSarah Marion, Spiros Tzivelekis, Christina Darden, et al.
Pest Management Science|February 21, 2020
A standardised bioassay method using a bench-top spray tower to evaluate entomopathogenic fungi for control of the greenhouse whitefly, Trialeurodes vaporariorumEleanor L Spence, David Chandler, Steve Edgington, et al.
Pain and Therapy|August 23, 2024
Changes in Use of Migraine Medications, Healthcare Resource Utilization, and Associated Direct Costs Over 12 Months Following Initiation of Erenumab: A US Retrospective Real-World AnalysisRobert Urman, Nicole Princic, Fiston Vuvu, et al.
BMC Cancer|August 11, 2019
Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational studyDerek Weycker, Robin Doroff, Ahuva Hanau, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Molecular Genetics and Metabolism|February 10, 2006
Founder mutation causing infantile GM1-gangliosidosis in the Gypsy populationIvanka Sinigerska, David Chandler, Vijesh Vaghjiani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2019
Trends in the use of primary prophylactic colony-stimulating factors and neutropenia-related hospitalization in elderly cancer patients receiving myelosuppressive chemotherapy in the USA: 1995-2015Shuling Li, Jiannong Liu, Haifeng Guo, et al.
Physical Review Letters|August 29, 2014
Charge fluctuations in nanoscale capacitorsDavid T Limmer, Céline Merlet, Mathieu Salanne, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 9, 2017
Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional surveyA Brett Hauber, Brennan Mange, Mark A Price, et al.
Clinical and Experimental Dermatology|August 22, 2024
Tinea capitis in older people: clinical experience of 36 cases over 10 yearsAlexandro Bonifaz, María Alejandra Chacón-Ruiz, Javier Araiza, et al.
BMC Cancer|January 19, 2023
Patient perspectives on considerations, tradeoffs, and experiences with multiple myeloma treatment selection: a qualitative descriptive studyCarrie Dombeck, Teresa Swezey, Juan Marcos Gonzalez Sepulveda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2016
"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationaleSarah Marion, Spiros Tzivelekis, Christina Darden, et al.
Pest Management Science|February 21, 2020
A standardised bioassay method using a bench-top spray tower to evaluate entomopathogenic fungi for control of the greenhouse whitefly, Trialeurodes vaporariorumEleanor L Spence, David Chandler, Steve Edgington, et al.
Pain and Therapy|August 23, 2024
Changes in Use of Migraine Medications, Healthcare Resource Utilization, and Associated Direct Costs Over 12 Months Following Initiation of Erenumab: A US Retrospective Real-World AnalysisRobert Urman, Nicole Princic, Fiston Vuvu, et al.
BMC Cancer|August 11, 2019
Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational studyDerek Weycker, Robin Doroff, Ahuva Hanau, et al.
Pageof 17